Related Experiment Video
Updated: Jun 20, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1-42 levels
Reinhilde Mlekusch1, Christian Humpel
1Laboratory of Psychiatry and Experimental Alzheimers Research, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria.
Abstract:
Matrix metalloproteinases (MMPs), a family of extracellular soluble or membrane bound endopeptidases, are implicated in many physiological and pathophysiological functions-based on their capability to cleave all protein components of the extracellular matrix. Recent studies have implicated several forms of MMPs in chronic neurodegenerative diseases like Alzheimer's disease (AD), vascular dementia (VD), and Parkinson's disease (PD). The aim of the present study was to analyse eight MMPs (MMP-1, -2, -3, -7, -8, -9, -10, -13) in the human cerebrospinal fluid (CSF) and to correlate with the well established biomarkers beta-amyloid(1-42) (Abeta), total-tau and phospho-tau-181. Our data show a significant decrease of MMP-2 and MMP-3 levels in the CSF in samples with significantly reduced Abeta levels. It is concluded that MMP-2 and MMP-3 are directly linked to Abeta in the brain and a dysfunction may influence the processing of Abeta.
Insights
Matrix metalloproteinases (MMPs) are crucial in brain health. This study found decreased MMP-2 and MMP-3 levels in cerebrospinal fluid linked to lower beta-amyloid, suggesting their role in Alzheimer's disease pathology.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Matrix metalloproteinases (MMPs) are enzymes that degrade extracellular matrix proteins.
- MMPs are increasingly implicated in neurodegenerative diseases such as Alzheimer's disease (AD), vascular dementia (VD), and Parkinson's disease (PD).
Purpose of the Study:
- To analyze eight matrix metalloproteinases (MMP-1, -2, -3, -7, -8, -9, -10, -13) in human cerebrospinal fluid (CSF).
- To correlate MMP levels with established Alzheimer's disease biomarkers: beta-amyloid(1-42) (Abeta), total-tau, and phospho-tau-181.
Main Methods:
- Analysis of eight MMPs in human CSF samples.
- Correlation analysis between MMP levels and Abeta, total-tau, and phospho-tau-181 concentrations.
Main Results:
- Significant decrease in MMP-2 and MMP-3 levels observed in CSF samples with reduced Abeta levels.
- MMP-2 and MMP-3 levels showed a significant inverse correlation with Abeta concentrations.
Conclusions:
- MMP-2 and MMP-3 are directly linked to beta-amyloid processing in the brain.
- Dysfunction of MMP-2 and MMP-3 may play a role in the pathogenesis of Alzheimer's disease by influencing Abeta metabolism.
More Related Videos
08:08A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse
Published on: November 10, 2008
10:51Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting
Published on: April 10, 2014